You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 245 No. 11, March 20, 1981 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (99)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Arterial Chemoembolization With Microencapsulated Anticancer Drug

An Approach to Selective Cancer Chemotherapy With Sustained Effects

Tetsuro Kato, MD; Ryosuke Nemoto, MD; Hisashi Mori, MD; Mutsumasa Takahashi, MD; Yoshiharu Tamakawa, MD; Mosaoki Harada, MD

JAMA. 1981;245(11):1123-1127.


Abstract

Selective intra-arterial infusion of ethylcellulose microcapsules containing mitomycin exerts its therapeutic effects through infarction and sustained drug action—ie, chemoembolization. Sixty primary or secondary carcinomas in the kidney, liver, urinary bladder, prostate, cervix, vagina, sigmoid colon, Douglas' pouch, and bone were treated with single or repeated chemoembolizations using microcapsules delivered through percutaneous catheterization as a preoperative or palliative measure. Substantial tumor reduction of greater than 30% in measurable maximum diameter was found in 65% of the tumors; pain relief occurred in 80% and hemostasis in 100%. Preoperative chemoembolization remarkably facilitated radical surgery in 18 (82%) of 22 patients. The summed response rate was 77%. Systemic toxic effects were mild, and all patients tolerated the treatment. Though the follow-up periods are less than two years, 37 patients are alive with or without tumor.

(JAMA 1981;245:1123-1127)



Author Affiliations

From the Departments of Urology (Drs Kato, Nemoto, and Mori), Radiology (Drs Takahashi and Tamakawa), and Pathology (Dr Harada), Akita University School of Medicine, Akita, Japan.


Footnotes

Reprint requests to Department of Urology, Akita University School of Medicine, 1-1-1 Hondo, Akita 010, Japan (Dr Kato).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Embolization with Polyhydroxybutyrate (PHB) Microspheres: In-Vivo Studies
Kassab et al.
Journal of Bioactive and Compatible Polymers 1999;14:291-303.
ABSTRACT  

Percolation and Release of Cisplatin Loaded in Poly(lactide-co-glycolide) Microspheres for Chemoembolization
Deyme et al.
Journal of Bioactive and Compatible Polymers 1992;7:149-160.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.